Good News from SCOTUS on Gene Patents, But Questions Remain
What goes unaddressed by the justices is the patentability of cDNA based on common genetic variants in cancer. Those are “naturally occurring” mutations, inasmuch as they arise in humans….And the Supremes need to know about biology.